{
  "trial_id": "NCT00325507",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Locally advanced or metastatic, histologically proven clear cell or papillary cell renal carcinoma.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Primary tumour surgically removed.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Progressive disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "At least four weeks from any previous therapy for renal cancer.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fit for first or second line immunotherapy with subcutaneous low dose IL-2",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurable disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Aged 18 years or more.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Karnofsky score \u2265 80%",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Corrected calcium \u2265 10 g/dL (2.5 mmols/L)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Clinically immunocompetent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Free of clinically apparent autoimmune disease.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Haemoglobin \u2265 9 g/dL, total white cell count \u2265 3 x 10^9/L and lymphocyte count \u2265 1 x 10^9/dL",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous immunotherapy with any schedule of IL-2.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Intercurrent serious infections within the 28 days prior to entry into the trial.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient is a 55 year old man with lower urinary tract symptoms. He has a history of prostate volume (TRUS): 60 mL and Prostate-specific antigen (PSA) level: 3.2 ng/mL.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT00325507",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}